Search

everythinglearnresearchcommunity

for

Search:↓

New compounds were made and tested, with compound 6 showing potential for treating prostate-related diseases.

PM-9 and finasteride effectively inhibit the enzyme that converts testosterone to DHT.

Finasteride and dutasteride's effects are mainly due to target binding saturation and slow enzyme turnover.

Cepharanthine analogues, especially tetrandrine, show potential for treating COVID-19.

Mice with enhanced regeneration abilities may help develop new regenerative medicine therapies.

The new compounds may be more effective and cheaper than current treatments for conditions like baldness.

The method is quick and effective for testing steroid 5 alpha-reductase inhibitors.

Protease Nexin-1 is found in human hair growth cells and is affected by male hormones.

Finasteride modifies 5-alpha-reductases through a two-step process, affecting inhibitor potency and possibly causing side effects.

Increasing alkaline phosphatase in human skin cells helps to grow more hair.

Finasteride breaks down into new compounds under acidic conditions.

A new drug, dutasteride, is at least as effective as the older drug, finasteride, for treating enlarged prostate and may have additional uses.

Using 5-butylpicolinate esters improves the sensitivity and reliability of detecting testosterone and dihydrotestosterone in saliva.

NM2 and RLC phosphorylation are essential for normal inner ear hair cell function.

Different animals have unique versions of the enzyme that changes testosterone into another hormone, which is important for creating effective treatments for prostate and hair loss conditions.

PTHrP regulates various normal body functions, including bone development, skin, and muscle function.

Changing the 6-position on benzopyran molecules affects insulin release, with some compounds showing strong inhibitory effects.

Phosphorus limitation causes significant hair growth in certain algae.

Apyrase enzymes control ATP levels in Arabidopsis root growth zones.

Marine compounds from gorgonians and soft corals show promise for drug development, especially for chronic disorders.

New research is needed to create better drugs that block the enzyme responsible for conditions like male baldness and prostate enlargement.

A new compound may treat benign prostatic hyperplasia better than finasteride.

Certain drugs that block specific enzymes can help treat prostate diseases.

Targeting PTEN can improve healing in venous leg ulcers.

Soybean root hair growth under low phosphate relies on specific transporters and transcription factors.

Balanced protease activity is crucial for healthy skin and hair development.

Dobutamine does not mimic dopamine at therapeutic doses but may at very high concentrations; microfilaments, not microtubules, are important for wound healing in Xenopus embryos.

Carbamates may help treat androgen-dependent conditions by changing how certain lipid enzymes are produced.

Targeted protein degraders show promise in treating cancer but need to target more diverse proteins.

The MAPK/ERK pathway is crucial in controlling cell growth and death in finasteride-induced hypospadias.